LEMAITRE VASCULAR INC (LMAT) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for LEMAITRE VASCULAR INC (LMAT): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 64/100 — a percentile rank of LEMAITRE VASCULAR INC’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.
| Market cap | $1.8B |
| P / E | 27.9× |
| P / S | 7.0× |
| EV / EBITDA | 22.5× |
| Gross margin | 72.9% |
| Operating margin | 29.5% |
| Net margin | 25.0% |
| Return on equity | 15.6% |
| ROIC | 10.6% |
| Revenue growth | 11.8% |
| Debt / equity | 0.4× |
| Dividend yield | 1.1% |
Is LEMAITRE VASCULAR INC overvalued? P/E looks undervalued vs its 5-year range; P/S looks fair vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from LEMAITRE VASCULAR INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact